Overall, our results suggest that analysis of p53 posttranslational modifications, in combination with TTC5 expression, upon further testing on a larger number of patients, may provide further insight into the role of p53 pathway in lung cancer biology. This evidence concerns the gene TTC5 and lung carcinoma.